Hualan Biological Engineering
002007.SZ
#3099
Rank
NZ$7.04 B
Marketcap
$3.85
Share price
-0.25%
Change (1 day)
-7.61%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2024 (TTM): NZ$0.38 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are NZ$0.69 Billion. In 2023 the company made an earning of NZ$0.51 Billion, an increase over its 2022 earnings that were of NZ$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.38 B-24.84%
2023 NZ$0.51 B39.21%
2022 NZ$0.37 B-19.12%
2021 NZ$0.46 B-17.9%
2020 NZ$0.56 B37.11%
2019 NZ$0.40 B11.71%
2018 NZ$0.36 B50.84%
2017 NZ$0.24 B1.1%
2016 NZ$0.24 B23.49%
2015 NZ$0.19 B8.37%
2014 NZ$0.17 B10.83%
2013 NZ$0.16 B54.56%
2012 NZ$0.10 B-17.03%
2011 NZ$0.12 B-41.34%
2010 NZ$0.21 B6.15%
2009 NZ$0.20 B261.3%
2008 NZ$56.14 M85.75%
2007 NZ$30.22 M49.27%
2006 NZ$20.25 M56.98%
2005 NZ$12.9 M34.28%
2004 NZ$9.6 M